Which has stronger valuation and earnings, MMED or STE?

STERIS has higher revenue and earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiniMed Group $3.10B 1.79 -$333M -$0.68 N/A STERIS $5.94B 3.42 $782.30M $8.18 25.49

Does the media favor MMED or STE?

In the previous week, MiniMed Group had 2 more articles in the media than STERIS. MarketBeat recorded 5 mentions for MiniMed Group and 3 mentions for STERIS. MiniMed Group's average media sentiment score of 0.66 beat STERIS's score of 0.60 indicating that MiniMed Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive STERIS 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MMED or ZBH?

In the previous week, Zimmer Biomet had 1 more articles in the media than MiniMed Group. MarketBeat recorded 6 mentions for Zimmer Biomet and 5 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 0.66 beat Zimmer Biomet's score of 0.41 indicating that MiniMed Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Zimmer Biomet 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor PEN or MMED?

In the previous week, MiniMed Group had 4 more articles in the media than Penumbra. MarketBeat recorded 5 mentions for MiniMed Group and 1 mentions for Penumbra. MiniMed Group's average media sentiment score of 0.66 beat Penumbra's score of 0.20 indicating that MiniMed Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MiniMed Group 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to BAX or MMED?

In the previous week, Baxter International had 12 more articles in the media than MiniMed Group. MarketBeat recorded 17 mentions for Baxter International and 5 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 0.66 beat Baxter International's score of -0.13 indicating that MiniMed Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral MiniMed Group 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, MMED or SNN?

Smith & Nephew SNATS has higher revenue and earnings than MiniMed Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiniMed Group $3.10B 1.79 -$333M -$0.68 N/A Smith & Nephew SNATS $6.16B 1.80 $625M N/A N/A

Is MMED or SNN more profitable?

Company Net Margins Return on Equity Return on Assets MiniMed Group N/A N/A N/A Smith & Nephew SNATS N/A N/A N/A

Does the media refer more to MMED or SNN?

In the previous week, MiniMed Group had 2 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 5 mentions for MiniMed Group and 3 mentions for Smith & Nephew SNATS. MiniMed Group's average media sentiment score of 0.66 beat Smith & Nephew SNATS's score of -0.01 indicating that MiniMed Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Smith & Nephew SNATS 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

MiniMed Group (MMED) Competitors

$19.70 0.00 (0.00%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$19.78 +0.08 (+0.43%)

As of 07:29 AM Eastern

Compare

MMED vs. STE, ZBH, PEN, BAX, and SNN

Should you buy MiniMed Group stock or one of its competitors? MiniMed Group's main competitors and comparable companies include STERIS (STE), Zimmer Biomet (ZBH), Penumbra (PEN), Baxter International (BAX), and Smith & Nephew SNATS (SNN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does MiniMed Group compare to STERIS?

MiniMed Group (NASDAQ:MMED) and STERIS (NYSE:STE) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk.

STERIS has a net margin of 13.34% compared to MiniMed Group's net margin of 0.00%. STERIS's return on equity of 14.34% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
STERIS	13.34%	14.34%	9.66%

STERIS has higher revenue and earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.10B	1.79	-$333M	-$0.68	N/A
STERIS	$5.94B	3.42	$782.30M	$8.18	25.49

In the previous week, MiniMed Group had 2 more articles in the media than STERIS. MarketBeat recorded 5 mentions for MiniMed Group and 3 mentions for STERIS. MiniMed Group's average media sentiment score of 0.66 beat STERIS's score of 0.60 indicating that MiniMed Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
STERIS	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

94.7% of STERIS shares are held by institutional investors. 0.0% of MiniMed Group shares are held by insiders. Comparatively, 1.1% of STERIS shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

MiniMed Group presently has a consensus price target of $24.14, suggesting a potential upside of 22.55%. STERIS has a consensus price target of $271.33, suggesting a potential upside of 30.15%. Given STERIS's higher probable upside, analysts plainly believe STERIS is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.76
STERIS	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Summary

STERIS beats MiniMed Group on 11 of the 15 factors compared between the two stocks.

How does MiniMed Group compare to Zimmer Biomet?

MiniMed Group (NASDAQ:MMED) and Zimmer Biomet (NYSE:ZBH) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

In the previous week, Zimmer Biomet had 1 more articles in the media than MiniMed Group. MarketBeat recorded 6 mentions for Zimmer Biomet and 5 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 0.66 beat Zimmer Biomet's score of 0.41 indicating that MiniMed Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Zimmer Biomet	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

88.9% of Zimmer Biomet shares are held by institutional investors. 0.0% of MiniMed Group shares are held by insiders. Comparatively, 1.3% of Zimmer Biomet shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

MiniMed Group currently has a consensus price target of $24.14, indicating a potential upside of 22.55%. Zimmer Biomet has a consensus price target of $103.00, indicating a potential upside of 16.58%. Given MiniMed Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe MiniMed Group is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.76
Zimmer Biomet	2 Sell rating(s)	14 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.18

Zimmer Biomet has higher revenue and earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.10B	1.79	-$333M	-$0.68	N/A
Zimmer Biomet	$8.23B	2.05	$705.20M	$4.11	21.50

Zimmer Biomet has a net margin of 9.48% compared to MiniMed Group's net margin of 0.00%. Zimmer Biomet's return on equity of 13.12% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Zimmer Biomet	9.48%	13.12%	7.23%

Summary

Zimmer Biomet beats MiniMed Group on 11 of the 15 factors compared between the two stocks.

How does MiniMed Group compare to Penumbra?

Penumbra (NYSE:PEN) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

In the previous week, MiniMed Group had 4 more articles in the media than Penumbra. MarketBeat recorded 5 mentions for MiniMed Group and 1 mentions for Penumbra. MiniMed Group's average media sentiment score of 0.66 beat Penumbra's score of 0.20 indicating that MiniMed Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MiniMed Group	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

88.9% of Penumbra shares are held by institutional investors. 2.9% of Penumbra shares are held by company insiders. Comparatively, 0.0% of MiniMed Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Penumbra has a net margin of 10.67% compared to MiniMed Group's net margin of 0.00%. Penumbra's return on equity of 10.50% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	10.67%	10.50%	8.17%
MiniMed Group	N/A	N/A	N/A

Penumbra currently has a consensus target price of $367.07, suggesting a potential upside of 15.53%. MiniMed Group has a consensus target price of $24.14, suggesting a potential upside of 22.55%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts plainly believe MiniMed Group is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.76

Penumbra has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.40B	8.92	$177.69M	$4.07	78.07
MiniMed Group	$3.10B	1.79	-$333M	-$0.68	N/A

Summary

Penumbra beats MiniMed Group on 9 of the 15 factors compared between the two stocks.

How does MiniMed Group compare to Baxter International?

Baxter International (NYSE:BAX) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

90.2% of Baxter International shares are owned by institutional investors. 0.2% of Baxter International shares are owned by insiders. Comparatively, 0.0% of MiniMed Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Baxter International had 12 more articles in the media than MiniMed Group. MarketBeat recorded 17 mentions for Baxter International and 5 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 0.66 beat Baxter International's score of -0.13 indicating that MiniMed Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
MiniMed Group	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Baxter International presently has a consensus target price of $22.45, indicating a potential downside of 4.37%. MiniMed Group has a consensus target price of $24.14, indicating a potential upside of 22.55%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts plainly believe MiniMed Group is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.76

MiniMed Group has lower revenue, but higher earnings than Baxter International. MiniMed Group is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.08	-$957M	-$2.07	N/A
MiniMed Group	$3.10B	1.79	-$333M	-$0.68	N/A

MiniMed Group has a net margin of 0.00% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.27%	16.57%	5.24%
MiniMed Group	N/A	N/A	N/A

Summary

MiniMed Group beats Baxter International on 8 of the 15 factors compared between the two stocks.

How does MiniMed Group compare to Smith & Nephew SNATS?

MiniMed Group (NASDAQ:MMED) and Smith & Nephew SNATS (NYSE:SNN) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.

Smith & Nephew SNATS has higher revenue and earnings than MiniMed Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.10B	1.79	-$333M	-$0.68	N/A
Smith & Nephew SNATS	$6.16B	1.80	$625M	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Smith & Nephew SNATS	N/A	N/A	N/A

MiniMed Group currently has a consensus target price of $24.14, suggesting a potential upside of 22.55%. Smith & Nephew SNATS has a consensus target price of $31.91, suggesting a potential upside of 20.63%. Given MiniMed Group's stronger consensus rating and higher possible upside, equities analysts clearly believe MiniMed Group is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.76
Smith & Nephew SNATS	1 Sell rating(s)	10 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 0.0% of MiniMed Group shares are owned by company insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, MiniMed Group had 2 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 5 mentions for MiniMed Group and 3 mentions for Smith & Nephew SNATS. MiniMed Group's average media sentiment score of 0.66 beat Smith & Nephew SNATS's score of -0.01 indicating that MiniMed Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Smith & Nephew SNATS	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

MiniMed Group and Smith & Nephew SNATS tied by winning 5 of the 10 factors compared between the two stocks.

Get MiniMed Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MMED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MMED vs. The Competition

Export

Metric	MiniMed Group	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.54B	$5.45B	$7.14B	$13.26B
Dividend Yield	N/A	1.79%	2.53%	17.33%
P/E Ratio	-28.97	25.42	275.00	26.04
Price / Sales	1.79	68.17	609.31	91.95
Price / Cash	N/A	32.73	27.22	34.69
Price / Book	1.53	5.92	11.20	6.34
Net Income	-$333M	$147.52M	$3.50B	$381.61M
7 Day Performance	-3.86%	-1.59%	-1.98%	-0.73%
1 Month Performance	-15.38%	-5.05%	-6.31%	-4.68%
1 Year Performance	N/A	1.33%	7.98%	1.58%

MiniMed Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MMED MiniMed Group	2.8149 of 5 stars	$19.70 flat	$24.14 +22.6%	N/A	$5.54B	$3.10B	N/A	2,800
STE STERIS	4.8757 of 5 stars	$208.72 0.0%	$271.33 +30.0%	-14.0%	$20.37B	$5.94B	25.52	17,937	Analyst Upgrade
ZBH Zimmer Biomet	4.1645 of 5 stars	$91.08 +1.6%	$103.00 +13.1%	-12.4%	$17.36B	$8.23B	22.16	17,000
PEN Penumbra	2.5783 of 5 stars	$319.08 -0.2%	$367.07 +15.0%	+24.1%	$12.56B	$1.40B	78.40	4,700
BAX Baxter International	1.1093 of 5 stars	$23.39 -0.4%	$22.45 -4.0%	-1.7%	$12.08B	$11.24B	N/A	37,500	Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MMED) was last updated on 10/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MiniMed Group (MMED) Competitors

MMED vs. STE, ZBH, PEN, BAX, and SNN

How does MiniMed Group compare to STERIS?

Summary

How does MiniMed Group compare to Zimmer Biomet?

Summary

How does MiniMed Group compare to Penumbra?

Summary

How does MiniMed Group compare to Baxter International?

Summary

How does MiniMed Group compare to Smith & Nephew SNATS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MMED vs. The Competition

MiniMed Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MiniMed Group (MMED) Competitors

MMED vs. STE, ZBH, PEN, BAX, and SNN

How does MiniMed Group compare to STERIS?

Is MMED or STE more profitable?

Which has stronger valuation and earnings, MMED or STE?

Does the media favor MMED or STE?

Do institutionals and insiders hold more shares of MMED or STE?

Do analysts recommend MMED or STE?

Summary

How does MiniMed Group compare to Zimmer Biomet?

Does the media refer more to MMED or ZBH?

Do insiders & institutionals hold more shares of MMED or ZBH?

Do analysts prefer MMED or ZBH?

Which has stronger earnings and valuation, MMED or ZBH?

Is MMED or ZBH more profitable?

Summary

How does MiniMed Group compare to Penumbra?

Does the media favor PEN or MMED?

Do insiders & institutionals believe in PEN or MMED?

Is PEN or MMED more profitable?

Do analysts recommend PEN or MMED?

Which has better earnings and valuation, PEN or MMED?

Summary

How does MiniMed Group compare to Baxter International?

Do insiders and institutionals hold more shares of BAX or MMED?

Does the media refer more to BAX or MMED?

Do analysts prefer BAX or MMED?

Which has higher valuation & earnings, BAX or MMED?

Is BAX or MMED more profitable?

Summary

How does MiniMed Group compare to Smith & Nephew SNATS?

Which has higher earnings & valuation, MMED or SNN?

Is MMED or SNN more profitable?

Do analysts prefer MMED or SNN?

Do institutionals and insiders hold more shares of MMED or SNN?

Does the media refer more to MMED or SNN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MMED vs. The Competition

MiniMed Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools